Discovery of Adiponectin and its Future Prospect
Kazuhisa Maedaaa* and Yuji Matsuzawab
Affiliation
- aDepartment of Complementary & Alternative Medicine, Osaka University Graduate School of Medicine, Osaka Japan.
- b Director of Sumitomo Hospital Osaka Japan.
Corresponding Author
Kazuhisa Maeda, Department of Complementary & Alternative Medicine, Osaka University Graduate School of Medicine, Osaka Japan, Tel: +81-668793498; E-mail: kaz@cam.med.osaka-u.ac.jp
Citation
Kazuhisa, M., et al. Discovery of Adiponectin and its Future Prospect (2014) J Diabetes Obes 1(1): 8- 13..
Copy rights
© 2014 Kazuhisa, M. This is an Open access article distributed under the terms of Creative Commons Attribution 4.0 International License.
Abstract
Adiponectin is an adipocyte-specific protein abundantly present in the plasma. Since its discovery, numerous experimental and clinical studies have demonstrated that adiponectin has anti-atherogenic, antidiabetic and anti-inflammatory properties. Hypoadiponectinemia plays a key role in the pathogenesis of metabolic syndrome. In this manuscript, we review the discovery and establishment of adiponectin and discuss future prospects of this molecule.
